Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. (opent nieuw venster)

CRASH-3 Trial Collaborators

Bron‎: Lancet 2019;394(10210):1713-23.

Geïndexeerd‎: PubMed 31623894

DOI‎: 10.1016/S0140-6736(19)32233-0

https://www.ncbi.nlm.nih.gov/pubmed/31623894 (opent nieuw venster)

Alternatives to allogeneic platelet transfusion. (opent nieuw venster)

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ.

Bron‎: Br J Haematol 2016;175(3):381-92.

Geïndexeerd‎: PubMed 27650431

DOI‎: 10.1111/bjh.14338

https://www.ncbi.nlm.nih.gov/pubmed/27650431 (opent nieuw venster)

Tranexamic acid: less bleeding and less thrombosis? (opent nieuw venster)

Godier A, Roberts I, Hunt BJ.

Bron‎: Crit Care 2012;16(3):135.

Geïndexeerd‎: PubMed 22748073

DOI‎: 10.1186/cc11374

https://www.ncbi.nlm.nih.gov/pubmed/22748073 (opent nieuw venster)

Tranexamic acid for reducing mortality in emergency and urgent surgery. (opent nieuw venster)

Perel P, Ker K, Morales Uribe CH, Roberts I

Bron‎: Cochrane Database Syst Rev 2013;(1):CD010245.

Geïndexeerd‎: PubMed 23440847

DOI‎: 10.1002/14651858.CD010245.pub2

https://www.ncbi.nlm.nih.gov/pubmed/23440847 (opent nieuw venster)

The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. (opent nieuw venster)

Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T; CRASH-2 collaborators.

Bron‎: Lancet 2011;377(9771):1096-101, 1101.e1-2.

Geïndexeerd‎: PubMed 21439633

DOI‎: 10.1016/S0140-6736(11)60278-X

https://www.ncbi.nlm.nih.gov/pubmed/21439633 (opent nieuw venster)

Antifibrinolytic drugs for acute traumatic injury. (opent nieuw venster)

Roberts I, Shakur H, Ker K, Coats T; CRASH‐2 Trial collaborators.

Bron‎: Cochrane Database Syst Rev 2011;(1):CD004896.

Geïndexeerd‎: PubMed 21249666

DOI‎: 10.1002/14651858.CD004896.pub3

https://www.ncbi.nlm.nih.gov/pubmed/21249666 (opent nieuw venster)

Use of tranexamic acid to reduce bleeding in burns surgery. (opent nieuw venster)

Tang YM, Chapman TW, Brooks P

Bron‎: J Plast Reconstr Aesthet Surg 2012;65(5):684-6.

Geïndexeerd‎: PubMed 21983540

DOI‎: 10.1016/j.bjps.2011.09.028

https://www.ncbi.nlm.nih.gov/pubmed/21983540 (opent nieuw venster)

Tranexamic acid reduced blood transfusions in acute burn surgery: a retrospective case-controlled trial. (opent nieuw venster)

Tapking C, Hundeshagen G, Kirchner M, Fischer S, Kneser U, Bliesener B

Bron‎: Burns. 2022;48(3):522-28.

Geïndexeerd‎: PubMed 35339324

DOI‎: 10.1016/j.burns.2022.03.002

https://pubmed.ncbi.nlm.nih.gov/35339324/ (opent nieuw venster)

Salvage use of activated recombinant factor VII in the management of refractory bleeding following cardiac surgery. (opent nieuw venster)

Barua A, Rao VP, Ramesh B, Barua B, El-Shafei H.

Bron‎: J Blood Med 2011;2:131-4.

Geïndexeerd‎: PubMed 22287872

DOI‎: 10.2147/JBM.S21609

https://www.ncbi.nlm.nih.gov/pubmed/22287872 (opent nieuw venster)

The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage. (opent nieuw venster)

Boffard KD, Choong PI, Kluger Y, Riou B, Rizoli SB, Rossaint R, Warren B; NovoSeven Trauma Study Group.

Bron‎: Transfusion 2009;49 Suppl 5:240S-7S.

Geïndexeerd‎: PubMed 19954486

DOI‎: 10.1111/j.1537-2995.2008.01987.x

https://www.ncbi.nlm.nih.gov/pubmed/19954486 (opent nieuw venster)

The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding. (opent nieuw venster)

Fries D

Bron‎: Transfusion 2013;53 Suppl 1:91S-5S.

Geïndexeerd‎: PubMed 23301979

DOI‎: 10.1111/trf.12041

https://www.ncbi.nlm.nih.gov/pubmed/23301979 (opent nieuw venster)

A Jehovah's Witness with complex abdominal trauma and coagulopathy: use of factor VII and a review of the literature. (opent nieuw venster)

Haan J, Scalea T

Bron‎: Am Surg 2005;71(5):414-5.

Geïndexeerd‎: PubMed 15986972

https://www.ncbi.nlm.nih.gov/pubmed/15986972 (opent nieuw venster)

Results of the control trial: efficacy and safety of recombinant activated factor VII in the management of refractory traumatic hemorrhage. (opent nieuw venster)

Hauser CJ, Boffard K, Dutton R, Bernard GR, Croce MA, Holcomb JB, Leppaniemi A, Parr M, Vincent JL, Tortella BJ, Dimsits J, Bouillon B; CONTROL Study Group.

Bron‎: J Trauma 2010;69(3):489-500.

Geïndexeerd‎: PubMed 20838118

DOI‎: 10.1097/TA.0b013e3181edf36e

https://www.ncbi.nlm.nih.gov/pubmed/20838118 (opent nieuw venster)

Use of recombinant activated factor VII in patients without hemophilia: a meta-analysis of randomized control trials. (opent nieuw venster)

Hsia CC, Chin-Yee IH, McAlister VC.

Bron‎: Ann Surg 2008;248(1):61-8.

Geïndexeerd‎: PubMed 18580208

DOI‎: 10.1097/SLA.0b013e318176c4ec

https://www.ncbi.nlm.nih.gov/pubmed/18580208 (opent nieuw venster)

Rescue treatment with recombinant factor VIIa is effective in patients with life-threatening bleedings secondary to major wound excision: a report of four cases. (opent nieuw venster)

Johansson PI, Eriksen K, Alsbjørn B

Bron‎: J Trauma 2006;61(4):1016-8.

Geïndexeerd‎: PubMed 17033583

DOI‎: 10.1097/01.ta.0000239261.48022.f1

https://www.ncbi.nlm.nih.gov/pubmed/17033583 (opent nieuw venster)

Use of recombinant activated factor VII in Jehovah's Witness patients with critical bleeding. (opent nieuw venster)

Kandane-Rathnayake RK, Isbister JP, Zatta AJ, Aoki NJ, Cameron P, Phillips LE; Australian and New Zealand Haemostasis Registry Steering Committee

Bron‎: ANZ J Surg 2013;83(3):155-60.

Geïndexeerd‎: PubMed 23035873

DOI‎: 10.1111/j.1445-2197.2012.06285.x

https://www.ncbi.nlm.nih.gov/pubmed/23035873 (opent nieuw venster)

Recombinant factor VIIa in trauma patients with the 'triad of death.' (opent nieuw venster)

Mitra B, Cameron PA, Parr MJ, Phillips L.

Bron‎: Injury 2012;43(9):1409-14.

Geïndexeerd‎: PubMed 21345431

DOI‎: 10.1016/j.injury.2011.01.033

https://www.ncbi.nlm.nih.gov/pubmed/21345431 (opent nieuw venster)

Low-dose recombinant factor VIIa for trauma patients with coagulopathy. (opent nieuw venster)

Stein DM, Dutton RP, Hess JR, Scalea TM.

Bron‎: Injury 2008;39(9):1054-61.

Geïndexeerd‎: PubMed 18656871

DOI‎: 10.1016/j.injury.2008.03.032

https://www.ncbi.nlm.nih.gov/pubmed/18656871 (opent nieuw venster)

Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (Novoseven®). (opent nieuw venster)

Tanaka KA, Waly AA, Cooper WA, Levy JH.

Bron‎: Anesthesiology 2003;98(6):1513-5.

Geïndexeerd‎: PubMed 12766668

https://www.ncbi.nlm.nih.gov/pubmed/12766668 (opent nieuw venster)

Alternatives to allogeneic platelet transfusion. (opent nieuw venster)

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ.

Bron‎: Br J Haematol 2016;175(3):381-92.

Geïndexeerd‎: PubMed 27650431

DOI‎: 10.1111/bjh.14338

https://www.ncbi.nlm.nih.gov/pubmed/27650431 (opent nieuw venster)

The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding. (opent nieuw venster)

Fries D

Bron‎: Transfusion 2013;53 Suppl 1:91S-5S.

Geïndexeerd‎: PubMed 23301979

DOI‎: 10.1111/trf.12041

https://www.ncbi.nlm.nih.gov/pubmed/23301979 (opent nieuw venster)

Plasma fibrinogen level on admission to the intensive care unit is a powerful predictor of postoperative bleeding after cardiac surgery with cardiopulmonary bypass. (opent nieuw venster)

Kindo M, Hoang Minh T, Gerelli S, Perrier S, Meyer N, Schaeffer M, Bentz J, Announe T, Mommerot A, Collange O, Pottecher J, Cristinar M, Thiranos JC, Gros H, Mertes PM, Billaud P, Mazzucotelli JP

Bron‎: Thromb Res 2014;134(2):360-8.

Geïndexeerd‎: PubMed 24857189

DOI‎: 10.1016/j.thromres.2014.05.008

https://www.ncbi.nlm.nih.gov/pubmed/24857189 (opent nieuw venster)

Combination of recombinant factor VIIa and fibrinogen corrects clot formation in primary immune thrombocytopenia at very low platelet counts. (opent nieuw venster)

Larsen OH, Stentoft J, Radia D, Ingerslev J, Sørensen B

Bron‎: Br J Haematol 2013;160(2):228-36.

Geïndexeerd‎: PubMed 23151086

DOI‎: 10.1111/bjh.12118

https://www.ncbi.nlm.nih.gov/pubmed/23151086 (opent nieuw venster)

Strategies to reduce the use of blood products: a European perspective. (opent nieuw venster)

Theusinger OM, Felix C, Spahn DR.

Bron‎: Curr Opin Anaesthesiol 2012;25(1):59-65.

Geïndexeerd‎: PubMed 22113184

DOI‎: 10.1097/ACO.0b013e32834dec98

https://www.ncbi.nlm.nih.gov/pubmed/22113184 (opent nieuw venster)

Desmopressin reduces transfusion needs after surgery: a meta-analysis of randomized clinical trials. (opent nieuw venster)

Crescenzi G, Landoni G, Biondi-Zoccai G, Pappalardo F, Nuzzi M, Bignami E, Fochi O, Maj G, Calabrò MG, Ranucci M, Zangrillo A

Bron‎: Anesthesiology 2008;109(6):1063-76.

Geïndexeerd‎: PubMed 19034103

DOI‎: 10.1097/ALN.0b013e31818db18b

https://www.ncbi.nlm.nih.gov/pubmed/19034103 (opent nieuw venster)

Alternatives to allogeneic platelet transfusion. (opent nieuw venster)

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ.

Bron‎: Br J Haematol 2016;175(3):381-92.

Geïndexeerd‎: PubMed 27650431

DOI‎: 10.1111/bjh.14338

https://www.ncbi.nlm.nih.gov/pubmed/27650431 (opent nieuw venster)

Desmopressin in treatment of haematological disorders and in prevention of surgical bleeding. (opent nieuw venster)

Svensson PJ, Bergqvist PB, Juul KV, Berntorp E

Bron‎: Blood Rev 2014;28(3):95-102.

Geïndexeerd‎: PubMed 24703870

DOI‎: 10.1016/j.blre.2014.03.001

https://www.ncbi.nlm.nih.gov/pubmed/24703870 (opent nieuw venster)

Coagulopathy caused by vitamin K deficiency in critically ill, hospitalized patients. (opent nieuw venster)

Alperin JB

Bron‎: JAMA 1987;258(14):1916-9.

Geïndexeerd‎: PubMed 3656602

DOI‎: 10.1001/jama.1987.03400140078028

https://www.ncbi.nlm.nih.gov/pubmed/3656602 (opent nieuw venster)

Vitamin K deficiency and D-dimer levels in the intensive care unit: a prospective cohort study. (opent nieuw venster)

Crowther MA, McDonald E, Johnston M, Cook D

Bron‎: Blood Coagul Fibrinolysis 2002;13(1):49-52.

Geïndexeerd‎: PubMed 11994567

DOI‎: 10.1097/00001721-200201000-00007

https://www.ncbi.nlm.nih.gov/pubmed/11994567 (opent nieuw venster)

The use of fibrin sealant in burn operations. (opent nieuw venster)

Foster K

Bron‎: Surgery 2007;142(4 Suppl):S50-4.

Geïndexeerd‎: PubMed 18019939

DOI‎: 10.1016/j.surg.2007.06.026

https://www.ncbi.nlm.nih.gov/pubmed/18019939 (opent nieuw venster)

Use of fibrin sealant in thermal injury. (opent nieuw venster)

McGill V, Kowal-Vern A, Lee M, Greenhalgh D, Gomperts E, Bray G, Gamelli R

Bron‎: J Burn Care Rehabil 1997;18(5):429-34.

Geïndexeerd‎: PubMed 9313125

DOI‎: 10.1097/00004630-199709000-00011

https://www.ncbi.nlm.nih.gov/pubmed/9313125 (opent nieuw venster)

Perioperative treatment algorithm for bleeding burn patients reduces allogeneic blood product requirements. (opent nieuw venster)

Schaden E, Kimberger O, Kraincuk P, Baron DM, Metnitz PG, Kozek-Langenecker S

Bron‎: Br J Anaesth 2012;109(3):376-81.

Geïndexeerd‎: PubMed 22719014

DOI‎: 10.1093/bja/aes186

https://www.ncbi.nlm.nih.gov/pubmed/22719014 (opent nieuw venster)

Transfusion in trauma: why and how should we change our current practice? (opent nieuw venster)

Theusinger OM, Spahn DR, Ganter MT.

Bron‎: Curr Opin Anaesthesiol 2009;22(2):305-12.

Geïndexeerd‎: PubMed 19390257

DOI‎: 10.1097/ACO.0b013e3283212c7c

https://www.ncbi.nlm.nih.gov/pubmed/19390257 (opent nieuw venster)

Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis. (opent nieuw venster)

Whiting P, Al M, Westwood M, Ramos IC, Ryder S, Armstrong N, Misso K, Ross J, Severens J, Kleijnen J

Bron‎: Health Technol Assess 2015;19(58):1-228.

Geïndexeerd‎: PubMed 26215747

DOI‎: 10.3310/hta19580

https://www.ncbi.nlm.nih.gov/pubmed/26215747 (opent nieuw venster)